Literature DB >> 16049337

Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls.

Samir Kumar-Singh1, Daniel Pirici, Eileen McGowan, Sally Serneels, Chantal Ceuterick, John Hardy, Karen Duff, Dennis Dickson, Christine Van Broeckhoven.   

Abstract

Occurrence of amyloid beta (Abeta) dense-core plaques in the brain is one of the chief hallmarks of Alzheimer's disease (AD). It is not yet clear what factors are responsible for the aggregation of Abeta in the formation of these plaques. Using Tg2576 and PSAPP mouse models that exhibit age-related development of amyloid plaques similar to that observed in AD, we showed that approximately 95% of dense plaques in Tg2576 and approximately 85% in PSAPP mice are centered on vessel walls or in the immediate perivascular regions. Stereoscopy and simulation studies focusing on smaller plaques suggested that vascular associations for both Tg2576 and PSAPP mice were dramatically higher than those encountered by chance alone. We further identified ultrastructural microvascular abnormalities occurring in association with dense plaques. Although occurrence of gross cerebral hemorrhage was infrequent, we identified considerable infiltration of the serum proteins immunoglobulin and albumin in association with dense plaques. Together with earlier evidence of vascular clearance of Abeta, our data suggest that perturbed vascular transport and/or perivascular enrichment of Abeta leads to the formation of vasocentric dense plaques in Tg2576 and PSAPP mouse models of AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049337      PMCID: PMC1603563          DOI: 10.1016/S0002-9440(10)62995-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

Authors:  B A Yankner; L K Duffy; D A Kirschner
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

Review 2.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

3.  Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study.

Authors:  H Yamaguchi; T Yamazaki; C A Lemere; M P Frosch; D J Selkoe
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

4.  The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease.

Authors:  M Kawai; R N Kalaria; S I Harik; G Perry
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

Review 5.  Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review.

Authors:  L S Perlmutter; H C Chui
Journal:  Brain Res Bull       Date:  1990-05       Impact factor: 4.077

6.  Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.

Authors:  C L Joachim; J H Morris; D J Selkoe
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

7.  An immunohistochemical study of beta-protein in Alzheimer-type dementia brains.

Authors:  H Arai; N Sagi; I Noguchi; S Haga; T Ishii; Y Makino; K Kosaka
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

8.  Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.

Authors:  L Hendriks; C M van Duijn; P Cras; M Cruts; W Van Hul; F van Harskamp; A Warren; M G McInnis; S E Antonarakis; J J Martin
Journal:  Nat Genet       Date:  1992-06       Impact factor: 38.330

Review 9.  Molecular genetics of Alzheimer disease: identification of genes and gene mutations.

Authors:  C L Van Broeckhoven
Journal:  Eur Neurol       Date:  1995       Impact factor: 1.710

10.  Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala-->Gly mutation.

Authors:  P Cras; F van Harskamp; L Hendriks; C Ceuterick; C M van Duijn; S Z Stefanko; A Hofman; J M Kros; C Van Broeckhoven; J J Martin
Journal:  Acta Neuropathol       Date:  1998-09       Impact factor: 17.088

View more
  69 in total

1.  A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

Authors:  Rashid Deane; Itender Singh; Abhay P Sagare; Robert D Bell; Nathan T Ross; Barbra LaRue; Rachal Love; Sheldon Perry; Nicole Paquette; Richard J Deane; Meenakshisundaram Thiyagarajan; Troy Zarcone; Gunter Fritz; Alan E Friedman; Benjamin L Miller; Berislav V Zlokovic
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

2.  Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.

Authors:  Aaron Y Lai; Joanne McLaurin
Journal:  Future Neurol       Date:  2012-03-01

3.  Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.

Authors:  Yasmina Manso; Javier Carrasco; Gemma Comes; Gabriele Meloni; Paul A Adlard; Ashley I Bush; Milan Vašák; Juan Hidalgo
Journal:  Cell Mol Life Sci       Date:  2012-06-22       Impact factor: 9.261

Review 4.  Microglia in Health and Disease.

Authors:  Richard M Ransohoff; Joseph El Khoury
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-09-09       Impact factor: 10.005

5.  Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model.

Authors:  Yona Levites; Pritam Das; Robert W Price; Marjorie J Rochette; Lisa A Kostura; Eileen M McGowan; Michael P Murphy; Todd E Golde
Journal:  J Clin Invest       Date:  2005-12-08       Impact factor: 14.808

6.  Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease.

Authors:  Peter N Alexandrov; Aileen Pogue; Surjyadipta Bhattacharjee; Walter J Lukiw
Journal:  Neuroreport       Date:  2011-08-24       Impact factor: 1.837

Review 7.  Metallothionein and brain inflammation.

Authors:  Yasmina Manso; Paul A Adlard; Javier Carrasco; Milan Vašák; Juan Hidalgo
Journal:  J Biol Inorg Chem       Date:  2011-06-16       Impact factor: 3.358

Review 8.  Developmental and pathological angiogenesis in the central nervous system.

Authors:  Mario Vallon; Junlei Chang; Haijing Zhang; Calvin J Kuo
Journal:  Cell Mol Life Sci       Date:  2014-04-24       Impact factor: 9.261

9.  Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Anne B Rocher; Athena Ching-Jung Wang; William G M Janssen; Tony Flores; Gissel M Perez; James Schmeidler; Dara L Dickstein; Patrick R Hof; Gregory A Elder
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

Review 10.  Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.

Authors:  Thomas L Platt; Valerie L Reeves; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.